Please check your internet connection and try again.
# Magnesium Sulfate
## Overview
Magnesium sulfate is an essential mineral. It plays a role in numerous biochemical reactions, including energy production, nucleic acid and protein synthesis, neuromuscular transmission, and muscle contraction.
## Primary Indications
* Treatment of hypomagnesemia.
* Prevention and treatment of seizures in severe preeclampsia and eclampsia.
* Management of torsades de pointes.
* Treatment of status asthmaticus.
* Management of acute myocardial infarction (off-label, though some guidelines recommend it).
## Adult Dosing
* **Hypomagnesemia:**
* **Severe/Symptomatic:** 4-6 grams IV initially, followed by 1-2 grams/hour IV infusion. Daily maintenance dose typically 20-40 grams IV.
* **Mild/Asymptomatic:** 1 gram IV every 6 hours for 4 doses, or 1 gram IM every 6 hours for 4 doses.
* **Preeclampsia/Eclampsia:** Loading dose: 4-6 grams IV over 5-20 minutes. Maintenance infusion: 1-2 grams/hour IV. An alternative is 5 grams IM into each buttock.
* **Torsades de Pointes:** 1-2 grams IV in 50-100 mL D5W over 5-10 minutes. Repeat doses may be administered if indicated.
* **Status Asthmaticus:** 2 grams IV diluted in 50 mL normal saline infused over 15-20 minutes.
Dosing may vary based on local protocol and electrolyte levels.
## Pediatric Dosing
* **Hypomagnesemia:** 25-50 mg/kg/dose IV infused over 1-4 hours. Maximum dose 2 grams. Repeat every 6-12 hours as needed.
* **Status Asthmaticus:** 25-40 mg/kg IV infused over 15-30 minutes. Maximum dose 2 grams.
* **Preeclampsia/Eclampsia:** Not typically used in pediatric patients unless specifically indicated and managed by specialists.
Dosing requires careful titration and monitoring.
## Dose Adjustments
* **Renal Impairment:** Magnesium is renally excreted. In patients with impaired renal function, doses should be reduced and serum magnesium levels closely monitored to prevent accumulation and toxicity. Caution with CrCl < 30 mL/min.
## Contraindications
* Hypermagnesemia.
* Heart block.
* Myocardial infarction (relative contraindication in some cases, assess risk/benefit).
* Shock.
* Digitalis toxicity.
* Severe renal impairment.
## Adverse Effects
* **Common:** Flushing, sweating, warmth, hypotension, nausea, vomiting, drowsiness, decreased deep tendon reflexes.
* **Serious:** Respiratory depression, cardiac arrhythmias, cardiac arrest, loss of deep tendon reflexes, coma, hypermagnesemia.
## Key Drug Interactions
* **Calcium Salts:** May antagonize neuromuscular and cardiac effects of magnesium.
* **Neuromuscular Blockers (e.g., succinylcholine, rocuronium):** Magnesium can potentiate neuromuscular blockade, increasing the risk of prolonged paralysis and respiratory depression.
* **Nifedipine:** Concomitant use may lead to profound hypotension.
* **Tetracyclines and Bisphosphonates:** IV magnesium can decrease the absorption of these drugs; separate administration by at least 2-3 hours.
## Monitoring
* **Serum Magnesium Levels:** Regularly monitor, especially during prolonged infusions or in patients with renal impairment. Therapeutic range for hypomagnesemia is typically 1.7-2.2 mmol/L (4-5.5 mg/dL), but may be higher for specific indications (e.g., preeclampsia). Toxicity may occur above 4 mmol/L (10 mg/dL).
* **Renal Function:** Monitor creatinine and BUN.
* **Deep Tendon Reflexes:** Assess for depression or loss, an early sign of toxicity.
* **Respiratory Rate and Depth:** Monitor for signs of respiratory depression.
* **Electrocardiogram (ECG):** Monitor for QT interval prolongation or other arrhythmias, particularly in patients at risk.
* **Blood Pressure:** Monitor for hypotension.
## Clinical Pearls
* Magnesium sulfate is a CNS depressant and vasodilator.
* Rapid IV infusion can cause hypotension, flushing, and cardiac arrhythmias. Always dilute and infuse as recommended.
* IV calcium gluconate or calcium chloride is the antidote for magnesium toxicity.
* In preeclampsia, magnesium is given to prevent seizures, not to treat hypertension.
* Magnesium sulfate precipitates with calcium and phosphate. Do not mix in the same IV line.
***
*This information is intended for healthcare professionals and does not replace current prescribing information. Always consult the official drug monograph and institutional protocols for the most up-to-date and comprehensive guidance.*